Navigation Links
API Universal Foam Chin Strap

ProductsAPI Universal Foam Chin Strap
Company Anthony Products, Inc.
Item API Universal Foam Chin Strap
Features 
  • Ideal for use after otoplasties, neurosurgery, parotid, plastic, facial, eye, head and neck surgeries
  • Will not ravel and may be cut
  • Form to exact contours and pressure can be adjusted with the velcro closures
  • Hand or machine washable and is autoclavable
  • Also may be used for temporary splinting or bandaging, as well as for holding dressings in place
Description Form to exact contours
Info Anthony Products, Inc.
Customer Service: (800) 428-1610
Web site: http://www.anthonyproducts.com/

Related medicine products :

1. Universal Handle for Blades
2. Universal Trephine Handle with Cottingham Punch
3. Storz Universal Trephine Handle
4. Universal Conformer
5. Universal Eye Shield - child
6. Universal Eye Shield - adult
7. Universal Goffman Blue Eye Garter Shield Cover and Blue Eye Shield
8. Universal Trial Frames UB4
9. Universal Folding Forcep
10. Fine Universal II Inserter
11. Panther Universal Spinal Retractor System
Breaking Medicine Technology:FDA Makes Interim Recommendations to Address Concern of Excess Radiation Exposure during CT Perfusion Imaging 2FDA Makes Interim Recommendations to Address Concern of Excess Radiation Exposure during CT Perfusion Imaging 3Stallergenes: Oralair: Very Positive 3-Year Results of the Long-Term Study 2Stallergenes: Oralair: Very Positive 3-Year Results of the Long-Term Study 3Stallergenes: Oralair: Very Positive 3-Year Results of the Long-Term Study 4Stallergenes: Oralair: Very Positive 3-Year Results of the Long-Term Study 5Hill-Rom Announces Appointment of James R. Giertz to Board of Directors 2Contraceptive Pill Named the Greatest Pharmacy Invention of the Last 150 Years in Chemist+Druggist Competition 57518 1Contraceptive Pill Named the Greatest Pharmacy Invention of the Last 150 Years in Chemist+Druggist Competition 57518 2Bolder BioTechnology Receives 241 2 Million NIH Grant to Continue Development of Long Acting EPO Analog for Chronic Kidney Disease 14125 1Bolder BioTechnology Receives 241 2 Million NIH Grant to Continue Development of Long Acting EPO Analog for Chronic Kidney Disease 14125 2Bolder BioTechnology Receives 241 2 Million NIH Grant to Continue Development of Long Acting EPO Analog for Chronic Kidney Disease 14125 3Bolder BioTechnology Receives 241 2 Million NIH Grant to Continue Development of Long Acting EPO Analog for Chronic Kidney Disease 14125 4Alzheimers Foundation of America Applauds Inclusion of Cognitive Screening for Medicare Beneficiaries in Senate Finance Committee Health Reform Propos 57510 1Alzheimers Foundation of America Applauds Inclusion of Cognitive Screening for Medicare Beneficiaries in Senate Finance Committee Health Reform Propos 57510 2Alzheimers Foundation of America Applauds Inclusion of Cognitive Screening for Medicare Beneficiaries in Senate Finance Committee Health Reform Propos 57510 3